Postprandial Metabolism in Healthy Young Subjects
PoMet
1 other identifier
interventional
36
1 country
1
Brief Summary
This study aims to describe the dynamic changes in nutritional biomarkers in the blood during the postprandial period, i.e. the time period from the last meal and into the fasting state. In total 36 healthy, young men and women will be recruited in Bergen, Norway, and after receiving a standardized breakfast meal they will consume only water for the next 24 hours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2021
CompletedFirst Posted
Study publicly available on registry
August 4, 2021
CompletedStudy Start
First participant enrolled
August 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 9, 2021
CompletedJanuary 6, 2022
January 1, 2022
3 months
July 5, 2021
January 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolomics profile in serum during 24 hour fasting
Targeted metabolomics analyses of nutritional biomarkers related to B-vitamin status, one-carbon metabolism, and amino acids. All metabolite concentrations (Individual data + group geometric mean) will be presented for 14 prespecified timepoints after a standardized breakfast meal (15m, 30m, 45m, 60m, 90m, 2h, 3h, 4h, 6h. 8h, 10h, 12h, and 24h).
24 hours
Other Outcomes (3)
Sex differences
24 hours
Fasting vs nonfasting concentrations
24 hours
12h fasting metabolomic profile after day vs night fast
0 and 12 hours
Interventions
After the standardized breakfast meal, all participants will only consume water for 24 hours
Eligibility Criteria
You may qualify if:
- Body Mass Index between 22-27 kg/m\^2
- No significant weight change (\>5%) during the last 3 months before the study visit
- Female participants should use one of the following oral contraceptives: Almina, Loette, Melleva, Microgynon, Mirabella, or Oralcon
You may not qualify if:
- Acute or chronic disease such as diabetes, thyroid diseases, cancer, cardiovascular disease, or inflammatory bowel disease, during the last 3 years
- Celiac disease or other food allergies interfering with the standardized breakfast meal
- Use of any prescription medications
- Smoking or regular use of other nicotine-containing products
- Pregnancy or breastfeeding the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bergenlead
- Haukeland University Hospitalcollaborator
Study Sites (1)
Research Unit for Health Surveys, University of Bergen
Bergen, Vestland, 5009, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2021
First Posted
August 4, 2021
Study Start
August 16, 2021
Primary Completion
November 9, 2021
Study Completion
November 9, 2021
Last Updated
January 6, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Immediately following publication. No end date.
- Access Criteria
- Anyone can access the data
Deidentified raw data will be deposited in a national research data repository (dataverse.no)